Meta-analysis of prevention of surgical site infections following incision closure with triclosan-coated sutures: Robustness to new evidence

Surgical Infections

Volumn 15, Issue 3, 2014, Pages 165-181

  Daoud, Frederic C ^a   Edmiston, Charles E ^b   Leaper, David ^c  

^a Data Management and Biometrics   (France)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRICLOSAN; ANTIINFECTIVE AGENT; BIOMATERIAL;

CLINICAL ASSESSMENT; DISEASE CONTROL; HUMAN; INCISION; INFECTION PREVENTION; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SURGICAL INFECTION; SUTURE; SYSTEMATIC REVIEW; UNITED STATES; INCIDENCE; SURGICAL WOUND INFECTION; SUTURING METHOD;

ANTI-INFECTIVE AGENTS; COATED MATERIALS, BIOCOMPATIBLE; HUMANS; INCIDENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURGICAL WOUND INFECTION; SUTURE TECHNIQUES; TRICLOSAN;

EID: 84903146966     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2013.177     Document Type: Review

References (46)

1. Jones RD, Jampani HB, Newmann JL, et al. Triclosan; a review of effectiveness and safety in healthcare settings. Am J Infect Control 2000;28:184-196. (Pubitemid 30226494)
2. Bhargava HN, Leonard PA. Triclosan: Application and safety. Am J Infect Control 1996; 24: 209-218.
3. Rothenburger S, Spangler D, Bhende S, et al. In-vitro antimicrobial evaluation of coated Vicryl Plus antibacterial sutures (coated Polyglactin 910 with Triclosan) using zone of inhibition assay. Surg Infect 2002; 3: S79-S87.
4. Storch ML, Rothenburger SJ, Jacinto G. Experimental efficacy study of coated VICRYL plus antibacterial suture in guinea pigs challenged with Staphylococcus aureus. Surg Infect 2004;5:281-288. (Pubitemid 39462171)
5. In Ming X. et al. ''In vivo and in vitro antibacterial efficacy of PDS plus (polidioxanone with triclosan) suture. Surg Infect 2008;9:451-457.
6. Ethicon instruction for use: VICRYL Plus-389595.R04
7. Ethicon instruction for use: PDS Plus-389688.R02
8. Ethicon instruction for use: MONOCRYL Plus-389680.R02
9. Ford HR, Jones P, Gaines B, et al. Intraoperative handling and incision healing: Controlled clinical trial comparing coated Vicryl Plus antibacterial suture (coated polyglactin 910 with triclosan) with coated Vicryl suture (coated Polyglactin 910 suture). Surg Infect 2005;6:313-321. (Pubitemid 41645597)
10. Storch ML, Scalzo H, Van Lue S, et al. Physical and Functional Comparison of Coated VICRYL Plus Antibacterial Suture (Coated Polyglactin 910 Suture with Triclosan) with Coated VICRYL Suture (Coated Polyglactin 910 Suture) Surg Infect 2002;3 Suppl 1:S65-77.
11. Edmiston CE Jr, Daoud FC, Leaper D.: Is there an evidencebased argument for embracing an antimicrobial (triclosan)-coated suture technology to reduce the risk for surgical-site infections?: A meta-Analysis. Surgery 2013;154:89-100.
12. Rozzelle CJ, Leonardo J, Li V. Antimicrobial suture incision closure for cerebrospinal fluid shunt surgery: A prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr 2008;2:111-117.
13. Mingmalairak C, Ungbhakorn P, Paocharoen V. Efficacy of antimicrobial coating suture coated polyglactin 910 with triclosan (Vicryl plus) compared with polyglactin 910 (Vicryl) in reduced surgical site infection of appendicitis, double blind randomized control trial, preliminary safety report. J Med Assoc Thai 2009;92:770-775.
14. Zhuang CP, Cai GY, Wang YQ. Comparison of two absorbable sutures in abdominal wall incision. Journal of Clinical Rehabilitative Tissue Engineering Research 2009; 13: 4045-4048. (www.crter.cn CRTER website group Liao ICP 05011357 CRTER, submission: Ttp://oa.crter.org/ zglckfen/ch/index.aspx). Embase dx.doi.org/10.3969.
15. Zhang ZT, Zhang HW, Fang XD, et al. Pilot evaluation of cosmetic outcome and surgical site infection rates of coated vicryl plus antibacterial (polyglactin 910) suture compared to Chinese silk in scheduled breast cancer surgery. Chin Med J 2011;124:719-724.
16. Galal I, El-Hindawy K. Impact of using triclosan-Antibacterial sutures on incidence of surgical site infection. Am J Surg 2011;202:133-138.
17. Rasic Z, Schwarz D, Adam VN, et al. Efficacy of antimicrobial triclosan-coated polyglactin 910 (Vicryl Plus) suture for closure of the abdominal wall after colorectal surgery. Collegium Antropologicum 2011;35:439-443.
18. Williams N, Sweetland H, Goyal S, et al. Randomized trial of antimicrobial-coated sutures to prevent surgical site infection after breast cancer surgery. Surg Infect 2011;12: 469-474.
19. Baracs J, Huszar O, Sajjadi SG, et al. Surgical site infections after abdominal closure in colorectal surgery using triclosan-coated absorbable suture (PDS Plus) vs. uncoated sutures (PDS II): A randomized multicenter study. Surg Infect 2011;12:483-489.
20. Turtiainen J, Saimanen EI, Mäkinen KT, et al. Effect of triclosan-coated sutures on the incidence of surgical incision infection after lower limb revascularization surgery: A randomized controlled trial. World J Surg. 2012;36:2528-2534.
21. Seim BE, Tønnessen T, Woldbaek PR. Triclosan-coated sutures do not reduce leg incision infections after coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 2012;15:411-415.
22. Isik I, Selimen D, Senay S, et al. Efficiency of Antibacterial Suture Material in Cardiac Surgery: A Double-Blind Randomized Prospective Study. Heart Surg Forum. 2012;15:E40-45.
23. Nakamura T, Kashimura N, Noji T, et al. Triclosan-coated sutures reduce the incidence of incision infection and cost after colorectal surgery: A randomized controlled trial. Surgery 2013;153:576-583.
24. Moher D, Liberati A, Tetzlaff J, et al. The PRISMA Group. Preferred reporting items for systematic reviews and metaanalyses: The PRISMA statement. Open Med 2009;3:123-130.
25. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp. Epidemiol 1999;20:250-278.
26. Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: A modification of CDC definitions of surgical incision infections. Infect Control Hosp Epidemiol 1992;13: 606-608.
27. Centre for Evidence-Based Medicine, University of Oxford, UK. www.cebm.net. Last accessed July 30. 2013.
28. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 updated March 2011. www.cochrane-handbook.org.
29. Egger M, Davey Smith G, Schneider M, et al. Bias in metaanalysis detected by a simple, graphical test. Br Med J 1997;315:629-634. (Pubitemid 27387172)
30. Egger M, Davey Smith G. Bias in location and selection of studies. Br Med J 1998;316:61-66.
31. Sterne JAC, Egger M, Davey Smith G. Investigating and dealing with publication and other biases. In: Egger M, Davey Smith G, Altman DG (eds). Systematic Reviews in Health Care: Meta-Analysis in Context. London: BMJ Publishing Group, 2001:189-208.
32. Gavaghan DJ, Moore AR, McQay HJ. An evaluation of homogeneity tests in meta-Analysis in pain using simulations of patient data. Pain 2000;85:415-424. (Pubitemid 30214168)
33. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-Analysis. Statistics in Medicine 2002;21:1539-1558. (Pubitemid 34746062)
34. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-Analyses. Brit Med J 2003;327: 557-560. (Pubitemid 37088507)
35. Borenstein M, Larry V Hedges L, et al. A basic introduction to fixed-effect and random-effects models for metaanalysis. Res Syn Meth 2010;1:97-111.
36. DerSimonian R, Laird N. Meta-Analysis in Clinical Trials. Control Clin Trials 1986;7:177-188. (Pubitemid 17189972)
37. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp. Epidemiol 1999;20:250-278.
38. Thimour-Bergström L, Roman-Emanuel C, Schersten H, Friberg O, Gudbjartsson T, Jeppsson A. Triclosan-coated sutures reduce surgical site infection after open vein harvesting in coronary artery bypass grafting patients: A randomized controlled trial. Eur J Cardiothorac Surg 2013;44: 931-938.
39. Justinger C, Slotta JE, Ningel S, Gräber S, Kollmar O, Schilling MK. Surgical-site infection after abdominal wall closure with triclosan-impregnated poliydioxanone sutures: Results of a randomized clinical pathway facilitated trial (NCT00998907). Surgery 2013;154:589-595.
40. Defazio A, Datta M, Nezhat C. Does the use of Vicryl Plus antibacterial suture decrease the incidence of umbilical infection when compared to Vicryl suture? Fertil Steril 2005;84(suppl 1):S161;P-29.
41. Mattavelli I, Nespoli L, Alfieri S, et al. Effect of triclosancoated suture on surgical site infection after colorectal surgery: Final results of a multicenter, prospective, randomized trial. Surg Infect 2013;14(2):A9.
42. Singh H, Emmert MY, Sakaguchi,H, et al. Antibacterial suture reduces surgical site infections in coronary artery bypass grafting. Heart Surgery Forum. 2010;13(suppl 1): S85.
43. Khachatryan N, Dibirov M, Omelyanovsky V, et al. Prevention of postoperative infections in abdominal surgery using reabsorbable suture with antibacterial activity (vicryl plus) versus reabsorbable standard sutures. Surgical Infect 2013;12(2):A13-A14.
44. Hoaglin D, Frederick D, Mosteller F, Tukey J, eds. Understanding robust and exploratory data analysis. New York. John Wiley & Sons,1983:39,54,62, 223.
45. Wang ZX, Jiang CP, Cao Y, et al. Systematic review and meta-Analysis of triclosan-coated sutures for the prevention of surgical-site infection. Brit J Surg 2013;100:465-473.
46. Chang WK, Srinivasa S, Morton R, Hill AG. Triclosanimpregnated sutures to decrease surgical site infections: Systematic review and meta-Analysis of randomized trials. Ann Surg 2012;255:854-859.